19 June 2013
Keywords: hycamtin, gets, eu, ok, cervical, cancer, uk-based
Article | 11 December 2006
UK-based drug major GlaxoSmithKline says that the European Medicines Agency (EMEA) has approved its anticancer agent Hycamtin (topotecan
HCl), in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 December 2006
18 June 2013
© 2013 thepharmaletter.com